Health economic evaluations in reimbursement decision making in the Netherlands: time to take it seriously? [electronic resource]
- Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen 2014
- 383-9 p. digital
Cost-Benefit Analysis--economics Cross-Cultural Comparison Decision Making, Organizational Drug Costs--trends Forecasting Humans Insurance, Pharmaceutical Services--economics National Health Programs--economics Netherlands Quality-Adjusted Life Years Reimbursement Mechanisms--economics